Drug intelligence / Profile preview

Twenty-five-ingredient Pearl Pill

Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Twenty-five-ingredient Pearl Pill (Ershiwuwei Zhenzhu Wan) is a traditional Tibetan medicine (TTM) formulation first documented in the 8th-century classic text, the Four Medical Tantras. It is a multi-ingredient preparation composed of 25 distinct plant, animal, and mineral-derived substances, including pearl (margarita), pearl mother (margaritifera concha), nutmeg, saffron, and artificial musk. The formulation is widely used in China for the treatment of cerebrovascular and neurological disorders, particularly ischemic stroke, hemiplegia, facial paralysis, epilepsy, and vascular dementia. Preclinical studies suggest that it exerts neuroprotective, anti-inflammatory, and antioxidant effects, potentially by reducing the expression of inflammatory cytokines (such as TNF-alpha, IL-1beta, and IL-6), increasing superoxide dismutase (SOD) and catalase (CAT) activities, and inhibiting neuronal apoptosis through the upregulation of Bcl-2 and downregulation of caspase-3.

Brand names
GanluZang Nuo
Other names
EZPEr Shi Wu Wei Zhen Zhu WanErshiwuwei Zhenzhu PillsErshiwuwei Zhenzhu WanErshiwuwei ZhenzhuwanTwenty-Five Ingredients Pearl Pill

Beyond the preview

Go deeper on Twenty-five-ingredient Pearl Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Twenty-five-ingredient Pearl Pill.

Work on Twenty-five-ingredient Pearl Pill? Claim this page to correct or add information. Claim this page

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call